low dose ketamine for pain relief in CA breast patients for breast cancer surgery
Phase 4
- Conditions
- Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
- Registration Number
- CTRI/2024/05/067888
- Lead Sponsor
- niversity College Of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult female patients between 18-65 year of age, who are diagnosed as carcinoma breast and scheduled to undergo elective breast cancer surgery
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess and compare NRS-Pain scores and neuropathic pai. n in the study group S as compared to similar scores in control group C following breast cancer surgery at 1hour, 6 hours, 24 hours, 72 hours, 1 month, 2months and 3 months post-breast cancer surgery.Timepoint: To assess and compare NRS-Pain scores and neuropathic pain in the study group S as compared to similar scores in control group C following breast cancer surgery at 1hour, 6 hours, 24 hours, 72 hours, 1 month, 2months and 3 months post-breast cancer surgery.
- Secondary Outcome Measures
Name Time Method To assess and compare rescue analgesia required in the study group S as compared to control group C following breast cancer surgery. <br/ ><br>To assess and compare SF12 scores in the study group S as compared to control group C following breast cancer surgery. <br/ ><br>3To assess and compare adverse effects in the study group S as compared to control group C following breast cancer surgery. <br/ ><br> <br/ ><br>Timepoint: 1,6,24,72 hours <br/ ><br>1,2,3 months